PEDIATRICS Vol. 86 No. 1 July 1990, pp. 123-124
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abramson, J. S.
Right arrow Articles by Givner, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abramson, J. S.
Right arrow Articles by Givner, L. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Should Tetracycline Be Contraindicated for Therapy of Presumed Rocky Mountain Spotted Fever in Children Less Than 9 Years of Age?

Jon S. Abramson MD1 and Laurence B. Givner MD1

1 From the Department of Pediatrics, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina

Antibiotic treatment for suspected Rocky Mountain spotted fever usually must be started prior to confirmation of the diagnosis because of the following: (1) currently available laboratory diagnostic methods usually do not allow definitive diagnosis of Rocky Mountain spotted fever until the second week of illness, and (2) delays in the initiation of antimicrobial therapy until confirmation of diagnosis may lead to significant morbidity and mortality, the latter being as high as approximately 25% in untreated cases.1,2 In areas of high incidence, such as North Carolina, a heightened index of suspicion, especially during the season of peak incidence (May through September) means that a large number of patients with compatible signs and symptoms will be treated annually for presumed Rocky Mountain spotted fever.3

Submitted on April 27, 1989
Accepted on August 15, 1989


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Trop PediatrHome page
N. V. Tikare, P. R. Shahapur, L. H. Bidari, and B. G. Mantur
Rickettsial meningoencephalitis in a child--A case report
J Trop Pediatr, August 10, 2009; (2009) fmp065v1.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
B. Volovitz, R. Shkap, J. Amir, S. Calderon, I. Varsano, and M. Nussinovitch
Absence of Tooth Staining With Doxycycline Treatment in Young Children
Clinical Pediatrics, March 1, 2007; 46(2): 121 - 126.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
E. J. Masters, G. S. Olson, S. J. Weiner, and C. D. Paddock
Rocky Mountain Spotted Fever: A Clinician's Dilemma
Arch Intern Med, April 14, 2003; 163(7): 769 - 774.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
A. K. Shetty
Tetracyclines in Pediatrics Revisited
Clinical Pediatrics, May 1, 2002; 41(4): 203 - 209.
[PDF]

Home page
 PediatricsHome page
G. E. Schutze and R. F. Jacobs
Human Monocytic Ehrlichiosis in Children
Pediatrics, July 1, 1997; 100(1): e10 - e10.
[Abstract] [Full Text] [PDF]